113 related articles for article (PubMed ID: 22327154)
1. The cost of paediatric and perianal Crohn's disease in Canterbury, New Zealand.
Lion M; Gearry RB; Day AS; Eglinton T
N Z Med J; 2012 Feb; 125(1349):11-20. PubMed ID: 22327154
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of perianal Crohn's disease in a population-based cohort.
Eglinton TW; Barclay ML; Gearry RB; Frizelle FA
Dis Colon Rectum; 2012 Jul; 55(7):773-7. PubMed ID: 22706129
[TBL] [Abstract][Full Text] [Related]
3. Paediatric inflammatory bowel disease in New Zealand.
Yap J; Wesley A; Mouat S; Chin S
N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
[TBL] [Abstract][Full Text] [Related]
4. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
5. The cost of campylobacteriosis in New Zealand in 1995.
Withington SG; Chambers ST
N Z Med J; 1997 Jun; 110(1046):222-4. PubMed ID: 9236803
[TBL] [Abstract][Full Text] [Related]
6. Costs of depression in Catalonia (Spain).
Salvador-Carulla L; Bendeck M; Fernández A; Alberti C; Sabes-Figuera R; Molina C; Knapp M
J Affect Disord; 2011 Jul; 132(1-2):130-8. PubMed ID: 21402411
[TBL] [Abstract][Full Text] [Related]
7. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.
Tarrant KM; Barclay ML; Frampton CM; Gearry RB
Am J Gastroenterol; 2008 Dec; 103(12):3082-93. PubMed ID: 19086959
[TBL] [Abstract][Full Text] [Related]
8. [Cost of early management of chronic inflammatory intestinal disease].
Rolland N; Grandbastien B; Merle V; Gower-Rousseau C; Yzet T; Marti R; Lerebours E; Dupas JL; Czernichow P; Salomez JL; Lebrun T; Cortot A
Gastroenterol Clin Biol; 1999 Apr; 23(4):483-8. PubMed ID: 10416112
[TBL] [Abstract][Full Text] [Related]
9. Infliximab drug and infusion costs among patients with Crohn's disease in a commercially-insured setting.
Ollendorf DA; Lidsky L
Am J Ther; 2006; 13(6):502-6. PubMed ID: 17122530
[TBL] [Abstract][Full Text] [Related]
10. [Cost measurement based on a cost diary in patients with inflammatory bowel disease].
Rösch M; Leidl R; Tirpitz Cv; Reinshagen M; Adler G; König HH
Z Gastroenterol; 2002 Apr; 40(4):217-28. PubMed ID: 11961730
[TBL] [Abstract][Full Text] [Related]
11. Economic cost of community-acquired pneumonia in New Zealand adults.
Scott G; Scott H; Turley M; Baker M
N Z Med J; 2004 Jun; 117(1196):U933. PubMed ID: 15280937
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).
Hallert E; Husberg M; Jonsson D; Skogh T
Rheumatology (Oxford); 2004 Nov; 43(11):1374-82. PubMed ID: 15280570
[TBL] [Abstract][Full Text] [Related]
13. A claims-based Markov model for Crohn's disease.
Malone DC; Waters HC; Van Den Bos J; Popp J; Draaghtel K; Rahman MI
Aliment Pharmacol Ther; 2010 Aug; 32(3):448-58. PubMed ID: 20491743
[TBL] [Abstract][Full Text] [Related]
14. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
[TBL] [Abstract][Full Text] [Related]
15. Resource utilization and cost of rheumatic fever.
Terreri MT; Ferraz MB; Goldenberg J; Len C; Hilário MO
J Rheumatol; 2001 Jun; 28(6):1394-7. PubMed ID: 11409136
[TBL] [Abstract][Full Text] [Related]
16. Cost of coronary heart disease in New Zealand.
Scott WG; White HD; Scott HM
N Z Med J; 1993 Aug; 106(962):347-9. PubMed ID: 8255558
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of illness imposed by severe sepsis in Austria.
Schmid A; Schneider H; Adlof A; Smolle KH; Edelmann G; Sporn P; Frass M; Sumann G; Koller W; Schobersberger W
Wien Klin Wochenschr; 2002 Aug; 114(15-16):697-701. PubMed ID: 12602114
[TBL] [Abstract][Full Text] [Related]
18. The direct and indirect cost burden of Crohn's disease and ulcerative colitis.
Gibson TB; Ng E; Ozminkowski RJ; Wang S; Burton WN; Goetzel RZ; Maclean R
J Occup Environ Med; 2008 Nov; 50(11):1261-72. PubMed ID: 19001952
[TBL] [Abstract][Full Text] [Related]
19. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
[TBL] [Abstract][Full Text] [Related]
20. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease.
Gibson PR; Weston AR; Shann A; Florin TH; Lawrance IC; Macrae FA; Radford-Smith G
J Gastroenterol Hepatol; 2007 Aug; 22(8):1306-12. PubMed ID: 17559375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
